| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Personality Disorders | 55 | 2022 | 169 | 8.410 |
Why?
|
| Mental Disorders | 57 | 2023 | 888 | 7.970 |
Why?
|
| Psychotherapy | 26 | 2021 | 246 | 6.190 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 30 | 2022 | 229 | 6.030 |
Why?
|
| Borderline Personality Disorder | 36 | 2022 | 150 | 5.900 |
Why?
|
| Psychiatry | 23 | 2021 | 272 | 5.550 |
Why?
|
| Mental Health Services | 10 | 2021 | 269 | 2.560 |
Why?
|
| Suicide | 9 | 2020 | 203 | 2.440 |
Why?
|
| Models, Psychological | 11 | 2017 | 143 | 2.200 |
Why?
|
| Personality | 10 | 2022 | 114 | 1.880 |
Why?
|
| Humans | 216 | 2024 | 132013 | 1.820 |
Why?
|
| Depressive Disorder | 11 | 2017 | 476 | 1.710 |
Why?
|
| Inpatients | 18 | 2022 | 550 | 1.680 |
Why?
|
| Psychiatric Status Rating Scales | 35 | 2018 | 848 | 1.650 |
Why?
|
| Telemedicine | 5 | 2021 | 494 | 1.590 |
Why?
|
| Firearms | 3 | 2022 | 58 | 1.490 |
Why?
|
| Evidence-Based Medicine | 10 | 2020 | 662 | 1.470 |
Why?
|
| Stress Disorders, Post-Traumatic | 8 | 2022 | 648 | 1.360 |
Why?
|
| Bipolar Disorder | 10 | 2018 | 369 | 1.300 |
Why?
|
| Psychoanalytic Therapy | 9 | 2014 | 11 | 1.190 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2020 | 79 | 1.130 |
Why?
|
| Hospitals, Psychiatric | 12 | 2022 | 70 | 1.130 |
Why?
|
| Personality Inventory | 11 | 2021 | 179 | 1.090 |
Why?
|
| Adaptation, Psychological | 5 | 2017 | 451 | 1.050 |
Why?
|
| Personality Assessment | 14 | 2015 | 111 | 1.020 |
Why?
|
| Aging | 3 | 2024 | 1249 | 1.010 |
Why?
|
| Advisory Committees | 4 | 2013 | 151 | 0.900 |
Why?
|
| Object Attachment | 4 | 2022 | 55 | 0.880 |
Why?
|
| Internet | 2 | 2020 | 406 | 0.870 |
Why?
|
| Hospitalization | 16 | 2020 | 1897 | 0.870 |
Why?
|
| Societies, Medical | 8 | 2017 | 778 | 0.850 |
Why?
|
| Sports | 1 | 2024 | 66 | 0.840 |
Why?
|
| Depression | 10 | 2024 | 1339 | 0.820 |
Why?
|
| Adult | 73 | 2022 | 31563 | 0.820 |
Why?
|
| Psychometrics | 17 | 2016 | 687 | 0.810 |
Why?
|
| Antipsychotic Agents | 6 | 2010 | 381 | 0.800 |
Why?
|
| Anticonvulsants | 5 | 2008 | 390 | 0.800 |
Why?
|
| Violence | 6 | 2013 | 128 | 0.790 |
Why?
|
| Interpersonal Relations | 10 | 2014 | 233 | 0.790 |
Why?
|
| Hallucinogens | 1 | 2023 | 51 | 0.770 |
Why?
|
| Happiness | 1 | 2022 | 13 | 0.750 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 106 | 0.700 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 101 | 0.700 |
Why?
|
| Resilience, Psychological | 2 | 2021 | 80 | 0.700 |
Why?
|
| Surveys and Questionnaires | 7 | 2022 | 3993 | 0.690 |
Why?
|
| Mind-Body Therapies | 2 | 2012 | 12 | 0.680 |
Why?
|
| Physician-Patient Relations | 5 | 2013 | 448 | 0.670 |
Why?
|
| Consensus | 2 | 2013 | 649 | 0.650 |
Why?
|
| Prescription Drug Misuse | 1 | 2020 | 8 | 0.640 |
Why?
|
| Communication | 4 | 2016 | 542 | 0.640 |
Why?
|
| Racism | 1 | 2020 | 42 | 0.630 |
Why?
|
| Exercise Therapy | 1 | 2021 | 182 | 0.620 |
Why?
|
| Quality Indicators, Health Care | 3 | 2014 | 235 | 0.620 |
Why?
|
| Pain | 2 | 2020 | 457 | 0.610 |
Why?
|
| Depressive Disorder, Major | 8 | 2021 | 440 | 0.610 |
Why?
|
| Pedophilia | 1 | 2018 | 2 | 0.600 |
Why?
|
| Clergy | 1 | 2018 | 5 | 0.590 |
Why?
|
| Information Dissemination | 3 | 2017 | 200 | 0.590 |
Why?
|
| Family | 1 | 2022 | 595 | 0.580 |
Why?
|
| Minority Groups | 1 | 2020 | 249 | 0.570 |
Why?
|
| Emotions | 5 | 2018 | 367 | 0.570 |
Why?
|
| Health Education | 1 | 2020 | 235 | 0.570 |
Why?
|
| Pregnancy, Multiple | 1 | 2018 | 48 | 0.560 |
Why?
|
| Patient Rights | 2 | 2009 | 51 | 0.560 |
Why?
|
| Right to Die | 1 | 2017 | 2 | 0.550 |
Why?
|
| Polypharmacy | 2 | 2016 | 36 | 0.550 |
Why?
|
| Mental Health | 1 | 2021 | 370 | 0.550 |
Why?
|
| Risk Management | 2 | 2017 | 69 | 0.550 |
Why?
|
| Psychotic Disorders | 4 | 2017 | 150 | 0.540 |
Why?
|
| Male | 69 | 2022 | 64914 | 0.540 |
Why?
|
| Severity of Illness Index | 12 | 2017 | 3088 | 0.530 |
Why?
|
| United States | 25 | 2020 | 11655 | 0.530 |
Why?
|
| Sleep | 1 | 2020 | 374 | 0.530 |
Why?
|
| Substance-Related Disorders | 3 | 2019 | 491 | 0.520 |
Why?
|
| Anxiety | 3 | 2020 | 991 | 0.520 |
Why?
|
| Human Trafficking | 1 | 2018 | 59 | 0.520 |
Why?
|
| Referral and Consultation | 4 | 2019 | 569 | 0.510 |
Why?
|
| Universities | 2 | 2007 | 129 | 0.510 |
Why?
|
| Self Concept | 4 | 2015 | 164 | 0.500 |
Why?
|
| Disasters | 1 | 2017 | 106 | 0.500 |
Why?
|
| Self-Injurious Behavior | 2 | 2015 | 66 | 0.490 |
Why?
|
| Comorbidity | 20 | 2020 | 1604 | 0.490 |
Why?
|
| Mandatory Programs | 1 | 2015 | 6 | 0.490 |
Why?
|
| Attitude of Health Personnel | 5 | 2016 | 726 | 0.490 |
Why?
|
| Physician Impairment | 1 | 2015 | 10 | 0.490 |
Why?
|
| Personal Narratives as Topic | 1 | 2015 | 2 | 0.480 |
Why?
|
| Trauma and Stressor Related Disorders | 1 | 2015 | 1 | 0.480 |
Why?
|
| Lawyers | 1 | 2015 | 5 | 0.470 |
Why?
|
| Ambulatory Care | 8 | 2015 | 410 | 0.470 |
Why?
|
| Psychotropic Drugs | 6 | 2011 | 129 | 0.470 |
Why?
|
| Theory of Mind | 1 | 2015 | 28 | 0.470 |
Why?
|
| Attitude to Death | 2 | 2017 | 39 | 0.470 |
Why?
|
| Terminology as Topic | 5 | 2015 | 232 | 0.470 |
Why?
|
| Health Status | 3 | 2015 | 407 | 0.460 |
Why?
|
| Exercise | 1 | 2021 | 858 | 0.460 |
Why?
|
| Suicidal Ideation | 7 | 2022 | 254 | 0.460 |
Why?
|
| Anxiety Disorders | 6 | 2019 | 720 | 0.460 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2016 | 143 | 0.450 |
Why?
|
| Middle Aged | 39 | 2019 | 28968 | 0.450 |
Why?
|
| Female | 68 | 2022 | 70643 | 0.450 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 471 | 0.450 |
Why?
|
| Research | 3 | 2009 | 265 | 0.450 |
Why?
|
| Early Diagnosis | 1 | 2015 | 195 | 0.440 |
Why?
|
| Personal Autonomy | 1 | 2015 | 205 | 0.430 |
Why?
|
| Affective Symptoms | 1 | 2014 | 62 | 0.420 |
Why?
|
| Pain Management | 1 | 2016 | 196 | 0.420 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 59 | 0.420 |
Why?
|
| Survivors | 2 | 2012 | 354 | 0.410 |
Why?
|
| Guideline Adherence | 2 | 2008 | 393 | 0.410 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 180 | 0.400 |
Why?
|
| Mass Casualty Incidents | 1 | 2013 | 16 | 0.390 |
Why?
|
| Insurance, Health | 1 | 2013 | 144 | 0.390 |
Why?
|
| Social Change | 1 | 2012 | 15 | 0.380 |
Why?
|
| Patient Care Management | 1 | 2013 | 66 | 0.380 |
Why?
|
| Anomie | 1 | 2012 | 1 | 0.370 |
Why?
|
| Military Personnel | 1 | 2014 | 203 | 0.370 |
Why?
|
| International Agencies | 1 | 2012 | 30 | 0.370 |
Why?
|
| Adolescent | 30 | 2018 | 20544 | 0.370 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2012 | 6 | 0.370 |
Why?
|
| Sex Characteristics | 1 | 2014 | 327 | 0.370 |
Why?
|
| Placebo Effect | 1 | 2011 | 24 | 0.370 |
Why?
|
| Emergency Responders | 1 | 2012 | 18 | 0.370 |
Why?
|
| Warfare | 1 | 2012 | 34 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 5 | 2008 | 1300 | 0.360 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 485 | 0.360 |
Why?
|
| Young Adult | 17 | 2020 | 9952 | 0.360 |
Why?
|
| Models, Theoretical | 2 | 2011 | 391 | 0.360 |
Why?
|
| Social Media | 1 | 2014 | 120 | 0.360 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 347 | 0.360 |
Why?
|
| Social Adjustment | 3 | 2015 | 79 | 0.350 |
Why?
|
| Dangerous Behavior | 3 | 2007 | 11 | 0.350 |
Why?
|
| Safety | 2 | 2022 | 216 | 0.350 |
Why?
|
| Occupational Diseases | 1 | 2012 | 74 | 0.350 |
Why?
|
| Medicine | 2 | 2009 | 106 | 0.350 |
Why?
|
| Cultural Competency | 1 | 2012 | 53 | 0.340 |
Why?
|
| Review Literature as Topic | 2 | 2008 | 49 | 0.340 |
Why?
|
| Bereavement | 1 | 2011 | 21 | 0.340 |
Why?
|
| Cooperative Behavior | 3 | 2021 | 232 | 0.340 |
Why?
|
| Publishing | 2 | 2009 | 106 | 0.330 |
Why?
|
| Drug Monitoring | 2 | 2009 | 174 | 0.330 |
Why?
|
| Life Change Events | 1 | 2011 | 65 | 0.330 |
Why?
|
| Professional-Patient Relations | 3 | 2022 | 92 | 0.320 |
Why?
|
| Brain | 6 | 2021 | 3182 | 0.320 |
Why?
|
| Behavior Therapy | 2 | 2010 | 269 | 0.310 |
Why?
|
| Mood Disorders | 4 | 2016 | 129 | 0.310 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 355 | 0.300 |
Why?
|
| Longitudinal Studies | 10 | 2018 | 1500 | 0.300 |
Why?
|
| Fear | 4 | 2020 | 205 | 0.300 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 327 | 0.300 |
Why?
|
| Reproducibility of Results | 11 | 2018 | 3008 | 0.290 |
Why?
|
| Spirituality | 1 | 2009 | 50 | 0.290 |
Why?
|
| Human Experimentation | 2 | 1999 | 35 | 0.290 |
Why?
|
| Metformin | 1 | 2010 | 166 | 0.290 |
Why?
|
| Cognition | 1 | 2014 | 810 | 0.290 |
Why?
|
| Personality Development | 3 | 2011 | 15 | 0.280 |
Why?
|
| Medication Adherence | 1 | 2011 | 326 | 0.280 |
Why?
|
| Drug Approval | 1 | 2008 | 46 | 0.280 |
Why?
|
| Factor Analysis, Statistical | 4 | 2016 | 236 | 0.280 |
Why?
|
| Weight Gain | 1 | 2010 | 381 | 0.280 |
Why?
|
| Risperidone | 1 | 2008 | 60 | 0.270 |
Why?
|
| United States Food and Drug Administration | 1 | 2008 | 160 | 0.270 |
Why?
|
| Valproic Acid | 1 | 2008 | 163 | 0.270 |
Why?
|
| Veterans | 1 | 2019 | 1760 | 0.260 |
Why?
|
| Homicide | 1 | 2007 | 35 | 0.260 |
Why?
|
| Risk Assessment | 6 | 2020 | 3731 | 0.260 |
Why?
|
| Goals | 3 | 2021 | 133 | 0.260 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 365 | 0.260 |
Why?
|
| Health Behavior | 1 | 2010 | 399 | 0.260 |
Why?
|
| Community Mental Health Services | 1 | 2007 | 39 | 0.260 |
Why?
|
| Remission Induction | 2 | 2018 | 306 | 0.250 |
Why?
|
| New York | 7 | 2008 | 72 | 0.250 |
Why?
|
| Body Weight | 2 | 2010 | 994 | 0.250 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 482 | 0.250 |
Why?
|
| Schizotypal Personality Disorder | 3 | 2002 | 7 | 0.240 |
Why?
|
| Holistic Health | 1 | 2006 | 12 | 0.240 |
Why?
|
| Compulsive Personality Disorder | 3 | 2002 | 16 | 0.240 |
Why?
|
| Health Promotion | 1 | 2009 | 399 | 0.240 |
Why?
|
| Child Abuse | 2 | 2001 | 204 | 0.240 |
Why?
|
| Interview, Psychological | 4 | 2014 | 108 | 0.230 |
Why?
|
| Quality of Life | 1 | 2015 | 2157 | 0.230 |
Why?
|
| Cultural Diversity | 1 | 2005 | 71 | 0.230 |
Why?
|
| Students | 1 | 2007 | 263 | 0.220 |
Why?
|
| Terrorism | 1 | 2004 | 5 | 0.210 |
Why?
|
| Athletes | 1 | 2024 | 73 | 0.210 |
Why?
|
| Social Support | 3 | 2009 | 387 | 0.210 |
Why?
|
| Crisis Intervention | 2 | 2021 | 5 | 0.210 |
Why?
|
| Awareness | 1 | 2004 | 80 | 0.200 |
Why?
|
| Suicide, Attempted | 3 | 2020 | 154 | 0.200 |
Why?
|
| Schizophrenia | 2 | 2006 | 332 | 0.200 |
Why?
|
| Stress, Psychological | 2 | 2022 | 575 | 0.190 |
Why?
|
| Motivation | 2 | 2022 | 330 | 0.190 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2021 | 11 | 0.180 |
Why?
|
| Treatment Outcome | 12 | 2019 | 12987 | 0.180 |
Why?
|
| Time Factors | 7 | 2019 | 6441 | 0.180 |
Why?
|
| Diagnosis, Differential | 6 | 2018 | 1957 | 0.180 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 43 | 0.180 |
Why?
|
| Combined Modality Therapy | 5 | 2016 | 1294 | 0.170 |
Why?
|
| Research Design | 5 | 2009 | 742 | 0.170 |
Why?
|
| National Institute of Mental Health (U.S.) | 2 | 2016 | 13 | 0.170 |
Why?
|
| Prevalence | 9 | 2014 | 2655 | 0.170 |
Why?
|
| Health Services Accessibility | 3 | 2019 | 669 | 0.170 |
Why?
|
| Group Processes | 1 | 2021 | 52 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2004 | 767 | 0.170 |
Why?
|
| Psychotherapy, Brief | 1 | 2021 | 57 | 0.170 |
Why?
|
| Prognosis | 6 | 2018 | 5008 | 0.160 |
Why?
|
| Disability Evaluation | 2 | 2018 | 198 | 0.160 |
Why?
|
| Cyclohexanecarboxylic Acids | 3 | 2008 | 18 | 0.160 |
Why?
|
| Prospective Studies | 6 | 2020 | 6568 | 0.160 |
Why?
|
| Smartphone | 1 | 2020 | 45 | 0.160 |
Why?
|
| Amines | 3 | 2008 | 38 | 0.160 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 428 | 0.150 |
Why?
|
| Temporal Lobe | 1 | 2020 | 118 | 0.150 |
Why?
|
| Piperazines | 2 | 2007 | 255 | 0.150 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2011 | 45 | 0.150 |
Why?
|
| Self Report | 3 | 2018 | 549 | 0.150 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2008 | 172 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 3843 | 0.150 |
Why?
|
| Politics | 2 | 2017 | 62 | 0.150 |
Why?
|
| Mobile Applications | 1 | 2020 | 108 | 0.140 |
Why?
|
| ROC Curve | 3 | 2018 | 600 | 0.140 |
Why?
|
| Bioethics | 1 | 1999 | 74 | 0.140 |
Why?
|
| Government Regulation | 1 | 1998 | 43 | 0.140 |
Why?
|
| Mental Competency | 1 | 1998 | 53 | 0.140 |
Why?
|
| Virginia | 2 | 2007 | 21 | 0.140 |
Why?
|
| Empathy | 1 | 2017 | 64 | 0.130 |
Why?
|
| Dependent Personality Disorder | 2 | 1996 | 2 | 0.130 |
Why?
|
| Coercion | 1 | 2017 | 26 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2017 | 492 | 0.130 |
Why?
|
| Quality of Health Care | 2 | 2014 | 422 | 0.130 |
Why?
|
| Decision Making | 2 | 2013 | 700 | 0.120 |
Why?
|
| Drug Interactions | 2 | 2008 | 246 | 0.120 |
Why?
|
| Odds Ratio | 5 | 2007 | 1254 | 0.120 |
Why?
|
| Somatoform Disorders | 1 | 2016 | 45 | 0.120 |
Why?
|
| Individuality | 1 | 2015 | 37 | 0.120 |
Why?
|
| Utilization Review | 2 | 2007 | 40 | 0.120 |
Why?
|
| Affect | 2 | 2009 | 173 | 0.120 |
Why?
|
| Placebos | 3 | 2011 | 234 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2020 | 907 | 0.120 |
Why?
|
| Child | 9 | 2018 | 25765 | 0.110 |
Why?
|
| Neurotic Disorders | 1 | 2014 | 6 | 0.110 |
Why?
|
| Anniversaries and Special Events | 1 | 2014 | 10 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2005 | 1256 | 0.110 |
Why?
|
| Disease Progression | 2 | 2018 | 2226 | 0.110 |
Why?
|
| Personality Tests | 1 | 2014 | 17 | 0.110 |
Why?
|
| Emergency Services, Psychiatric | 1 | 1995 | 23 | 0.110 |
Why?
|
| Brain Mapping | 1 | 2017 | 402 | 0.110 |
Why?
|
| Hostility | 1 | 2014 | 21 | 0.110 |
Why?
|
| Patient Admission | 2 | 2012 | 185 | 0.110 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 2311 | 0.110 |
Why?
|
| Medical Staff | 1 | 2014 | 7 | 0.110 |
Why?
|
| Impulsive Behavior | 2 | 2020 | 159 | 0.110 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2014 | 34 | 0.110 |
Why?
|
| Receptors, Serotonin | 1 | 1994 | 37 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 990 | 0.110 |
Why?
|
| Legislation as Topic | 1 | 2013 | 5 | 0.110 |
Why?
|
| Cross-Sectional Studies | 5 | 2016 | 3760 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 158 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2014 | 252 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 436 | 0.100 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2013 | 6 | 0.100 |
Why?
|
| Psychophysiology | 1 | 2013 | 9 | 0.100 |
Why?
|
| Pandemics | 1 | 2021 | 1183 | 0.100 |
Why?
|
| Serotonin | 1 | 1994 | 212 | 0.100 |
Why?
|
| Video Games | 1 | 2014 | 98 | 0.100 |
Why?
|
| Cognition Disorders | 2 | 2009 | 569 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2016 | 360 | 0.090 |
Why?
|
| Motivational Interviewing | 1 | 2013 | 48 | 0.090 |
Why?
|
| History, 21st Century | 2 | 2014 | 271 | 0.090 |
Why?
|
| Administrative Personnel | 1 | 2012 | 25 | 0.090 |
Why?
|
| Financing, Government | 1 | 2012 | 32 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 810 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2014 | 385 | 0.090 |
Why?
|
| Disease Management | 1 | 2015 | 562 | 0.090 |
Why?
|
| Aged | 7 | 2015 | 21406 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2020 | 17374 | 0.090 |
Why?
|
| Societies, Scientific | 1 | 2010 | 25 | 0.090 |
Why?
|
| Age of Onset | 2 | 2011 | 622 | 0.080 |
Why?
|
| Relaxation Therapy | 1 | 2010 | 17 | 0.080 |
Why?
|
| Social Stigma | 1 | 2011 | 85 | 0.080 |
Why?
|
| Ego | 1 | 2010 | 10 | 0.080 |
Why?
|
| Patient Participation | 1 | 2013 | 240 | 0.080 |
Why?
|
| Narcissism | 1 | 2009 | 7 | 0.080 |
Why?
|
| Military Psychiatry | 1 | 2009 | 1 | 0.080 |
Why?
|
| Prazosin | 1 | 2009 | 16 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 43 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2013 | 473 | 0.080 |
Why?
|
| Age Factors | 4 | 2017 | 2911 | 0.080 |
Why?
|
| Terminal Care | 1 | 2011 | 120 | 0.080 |
Why?
|
| Trust | 1 | 2010 | 83 | 0.080 |
Why?
|
| Psychology, Clinical | 1 | 2009 | 4 | 0.080 |
Why?
|
| Risk Factors | 6 | 2020 | 10931 | 0.080 |
Why?
|
| Health Care Reform | 1 | 2009 | 53 | 0.080 |
Why?
|
| Drug Therapy | 1 | 2009 | 87 | 0.070 |
Why?
|
| Books | 1 | 2008 | 6 | 0.070 |
Why?
|
| Implosive Therapy | 1 | 2010 | 98 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2014 | 699 | 0.070 |
Why?
|
| Drug Evaluation | 1 | 2008 | 106 | 0.070 |
Why?
|
| Social Marketing | 1 | 2008 | 9 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2008 | 45 | 0.070 |
Why?
|
| Authorship | 1 | 2008 | 29 | 0.070 |
Why?
|
| Psychotherapeutic Processes | 1 | 2007 | 4 | 0.070 |
Why?
|
| Reimbursement, Incentive | 1 | 2008 | 49 | 0.070 |
Why?
|
| Aripiprazole | 1 | 2007 | 22 | 0.070 |
Why?
|
| Haloperidol | 1 | 2007 | 23 | 0.070 |
Why?
|
| Writing | 1 | 2008 | 66 | 0.070 |
Why?
|
| Neurosciences | 1 | 2007 | 51 | 0.070 |
Why?
|
| Aggression | 1 | 2009 | 227 | 0.070 |
Why?
|
| Quinolones | 1 | 2007 | 58 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2011 | 572 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2009 | 5409 | 0.060 |
Why?
|
| Forecasting | 2 | 2009 | 372 | 0.060 |
Why?
|
| Freudian Theory | 1 | 2006 | 1 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 157 | 0.060 |
Why?
|
| Bulimia | 3 | 1996 | 15 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2012 | 698 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2006 | 119 | 0.060 |
Why?
|
| Therapeutic Community | 2 | 1983 | 3 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2007 | 166 | 0.060 |
Why?
|
| Texas | 1 | 2014 | 3627 | 0.060 |
Why?
|
| Cultural Characteristics | 1 | 2005 | 43 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2009 | 386 | 0.060 |
Why?
|
| Pregnancy | 1 | 2018 | 7554 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 322 | 0.060 |
Why?
|
| Institutionalization | 1 | 2005 | 16 | 0.060 |
Why?
|
| Patient Selection | 1 | 2008 | 732 | 0.050 |
Why?
|
| New York City | 1 | 2004 | 65 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2001 | 1044 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2008 | 198 | 0.050 |
Why?
|
| Social Isolation | 1 | 1983 | 48 | 0.050 |
Why?
|
| Language | 1 | 2005 | 224 | 0.050 |
Why?
|
| Chronic Disease | 3 | 2004 | 1234 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 1246 | 0.050 |
Why?
|
| Clinical Clerkship | 1 | 1983 | 83 | 0.050 |
Why?
|
| Patient Discharge | 2 | 2020 | 512 | 0.050 |
Why?
|
| Algorithms | 2 | 2018 | 1718 | 0.050 |
Why?
|
| Antisocial Personality Disorder | 1 | 2022 | 64 | 0.050 |
Why?
|
| Family Practice | 1 | 2002 | 92 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2005 | 291 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1983 | 159 | 0.040 |
Why?
|
| North America | 1 | 2002 | 265 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2008 | 1074 | 0.040 |
Why?
|
| Chest Pain | 1 | 2001 | 128 | 0.040 |
Why?
|
| Crime | 1 | 2000 | 26 | 0.040 |
Why?
|
| Benchmarking | 1 | 2001 | 138 | 0.040 |
Why?
|
| Reward | 1 | 2021 | 116 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 3 | 2009 | 59 | 0.040 |
Why?
|
| Learning | 1 | 1983 | 370 | 0.040 |
Why?
|
| Curriculum | 1 | 2005 | 767 | 0.040 |
Why?
|
| Risk | 2 | 2001 | 761 | 0.040 |
Why?
|
| Stereotyping | 1 | 1999 | 20 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2007 | 5166 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2006 | 793 | 0.040 |
Why?
|
| Human Rights | 1 | 1999 | 24 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2019 | 11 | 0.040 |
Why?
|
| Phenotype | 1 | 2009 | 4526 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3412 | 0.040 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2019 | 33 | 0.040 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2019 | 49 | 0.040 |
Why?
|
| Students, Medical | 1 | 1983 | 363 | 0.040 |
Why?
|
| Anorexia Nervosa | 2 | 1996 | 29 | 0.040 |
Why?
|
| Biomarkers | 1 | 2008 | 3402 | 0.040 |
Why?
|
| Aftercare | 1 | 2020 | 155 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 394 | 0.040 |
Why?
|
| Nontherapeutic Human Experimentation | 1 | 1998 | 7 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 1998 | 32 | 0.030 |
Why?
|
| State Government | 1 | 1998 | 30 | 0.030 |
Why?
|
| Third-Party Consent | 1 | 1998 | 28 | 0.030 |
Why?
|
| Self-Control | 1 | 2017 | 16 | 0.030 |
Why?
|
| Rest | 1 | 2017 | 66 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 1998 | 147 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 771 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2017 | 281 | 0.030 |
Why?
|
| Bed Occupancy | 1 | 1995 | 3 | 0.030 |
Why?
|
| Electronics | 1 | 2015 | 45 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2000 | 2139 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1351 | 0.030 |
Why?
|
| Informed Consent | 1 | 1998 | 346 | 0.030 |
Why?
|
| Biomedical Technology | 1 | 2015 | 36 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 1995 | 34 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2015 | 1057 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1995 | 277 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 828 | 0.030 |
Why?
|
| Adolescent, Hospitalized | 1 | 2014 | 7 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 588 | 0.030 |
Why?
|
| Depersonalization | 1 | 1994 | 10 | 0.030 |
Why?
|
| Anger | 1 | 1994 | 30 | 0.030 |
Why?
|
| Prolactin | 1 | 1994 | 113 | 0.030 |
Why?
|
| Internationality | 1 | 2014 | 133 | 0.030 |
Why?
|
| Alcoholism | 1 | 1996 | 250 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 713 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2013 | 24 | 0.020 |
Why?
|
| Feeding and Eating Disorders | 1 | 1993 | 76 | 0.020 |
Why?
|
| Beneficence | 1 | 2013 | 84 | 0.020 |
Why?
|
| Patient Simulation | 1 | 2013 | 41 | 0.020 |
Why?
|
| Communication Barriers | 1 | 2013 | 42 | 0.020 |
Why?
|
| Cost Control | 1 | 2012 | 24 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2012 | 28 | 0.020 |
Why?
|
| Criminal Law | 1 | 2012 | 14 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2005 | 795 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1994 | 696 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 35 | 0.020 |
Why?
|
| Hospitals, State | 1 | 1991 | 3 | 0.020 |
Why?
|
| Australia | 2 | 2002 | 185 | 0.020 |
Why?
|
| Health Care Rationing | 1 | 2012 | 63 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1996 | 1441 | 0.020 |
Why?
|
| Social Environment | 1 | 1992 | 122 | 0.020 |
Why?
|
| Canada | 2 | 2002 | 337 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 152 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 2013 | 401 | 0.020 |
Why?
|
| Netherlands | 1 | 2009 | 47 | 0.020 |
Why?
|
| Informatics | 1 | 2009 | 8 | 0.020 |
Why?
|
| Capital Financing | 1 | 2009 | 7 | 0.020 |
Why?
|
| Medical Laboratory Science | 1 | 2009 | 13 | 0.020 |
Why?
|
| Social Behavior | 1 | 2011 | 223 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 1160 | 0.020 |
Why?
|
| Textbooks as Topic | 1 | 2008 | 8 | 0.020 |
Why?
|
| Marketing | 1 | 2008 | 9 | 0.020 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2008 | 12 | 0.020 |
Why?
|
| Peer Review | 1 | 2008 | 37 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2008 | 67 | 0.020 |
Why?
|
| Sex Distribution | 2 | 2001 | 328 | 0.020 |
Why?
|
| Health Policy | 1 | 2009 | 233 | 0.020 |
Why?
|
| Logistic Models | 2 | 2001 | 1839 | 0.010 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2008 | 276 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2001 | 14736 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2000 | 482 | 0.010 |
Why?
|
| Periodicity | 1 | 1983 | 50 | 0.010 |
Why?
|
| Patient Advocacy | 1 | 1983 | 63 | 0.010 |
Why?
|
| Incidence | 1 | 1991 | 3375 | 0.010 |
Why?
|
| Attitude | 1 | 1983 | 120 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 215 | 0.010 |
Why?
|
| Teaching | 1 | 1983 | 201 | 0.010 |
Why?
|
| New England | 1 | 2001 | 12 | 0.010 |
Why?
|
| Problem Solving | 1 | 1982 | 68 | 0.010 |
Why?
|
| England | 1 | 2001 | 63 | 0.010 |
Why?
|
| Day Care, Medical | 1 | 2001 | 11 | 0.010 |
Why?
|
| Self-Help Groups | 1 | 2001 | 17 | 0.010 |
Why?
|
| Educational Measurement | 1 | 1983 | 329 | 0.010 |
Why?
|
| Psychology, Adolescent | 1 | 2000 | 35 | 0.010 |
Why?
|
| Age Distribution | 1 | 2001 | 438 | 0.010 |
Why?
|
| New South Wales | 1 | 2000 | 12 | 0.010 |
Why?
|
| New Zealand | 1 | 2000 | 60 | 0.010 |
Why?
|
| Data Collection | 1 | 2002 | 391 | 0.010 |
Why?
|
| Observer Variation | 1 | 2000 | 304 | 0.010 |
Why?
|
| Heart Rate | 1 | 2001 | 584 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 34804 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1999 | 430 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2001 | 1572 | 0.010 |
Why?
|
| Manuals as Topic | 2 | 1988 | 10 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2001 | 1400 | 0.010 |
Why?
|
| Phobic Disorders | 1 | 1995 | 43 | 0.010 |
Why?
|
| Desipramine | 1 | 1992 | 27 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1992 | 89 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1992 | 142 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1992 | 1656 | 0.000 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1995 | 831 | 0.000 |
Why?
|